YD Bio is a biotechnology business that is developing advancements in ophthalmology and DNA methylation-based cancer detection technology.
YD Bio has raised $13.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.
YD Bio is headquartered in Bothell, United States.
YD Bio is a biotechnology business that is developing advancements in ophthalmology and DNA methylation-based cancer detection technology.
YD Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"YD Bio — Funding & Investors." VCBacked, August 29, 2025, https://www.vcbacked.co/company/yd-bio. Accessed August 14, 2026.
VCBacked. (2025). YD Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/yd-bio
{{cite web |title=YD Bio — Funding & Investors |url=https://www.vcbacked.co/company/yd-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated